SHEENA PATEL: Open Payments
NPI 1932454709 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,287 in 168 payments from 21 companies in 2025. Trend: 2023 $72,767 · 2024 $34,898 · 2025 $5,287
Food & beverage: $3,912Speaker / faculty: $1,375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $2,245 |
| Janssen Pharmaceuticals, Inc | 18 | $644 |
| Teva Pharmaceuticals USA, Inc. | 20 | $434 |
| Neurocrine BioSciences, Inc. | 9 | $281 |
| Otsuka America Pharmaceutical, Inc. | 11 | $254 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $250 |
| Lundbeck LLC | 16 | $219 |
| Vanda Pharmaceuticals Inc. | 8 | $174 |
| Axsome Therapeutics, Inc. | 6 | $147 |
| Alkermes, Inc. | 6 | $129 |
Products named: VRAYLAR, SPRAVATO, AUSTEDO XR, INGREZZA, REXULTI, CAPLYTA, FANAPT, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
